SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: aknahow who wrote (5057)12/8/1997 2:10:00 PM
From: JFitnich  Read Replies (1) | Respond to of 17367
 
That was a pretty good article on IDEC. Ironically, I had a family
member who was very close that passed away as a result of Non-hodgkin's lymphoma. Strange that years later I would be
connected with it in some way as an investment.
I can say with complete confidence that any drug would be better
than the current treatments available. THe current treatments are
just nasty. No other word for it.

P.S. George, are you still in ICOS, that baby is rocketing and I
have no clue why. Makes me nervous.

SO long, JF



To: aknahow who wrote (5057)12/8/1997 3:17:00 PM
From: Andrew H  Read Replies (1) | Respond to of 17367
 
CLTR's drug, when approved may cut IDPH's market share, but it may just enlarge the market.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News